MaaT Pharma to hold FDA pre-IND meeting; advances MaaT034
MaaT Pharma said it will hold an upcoming pre-IND meeting with the FDA and is advancing MaaT034 toward clinical development in solid tumors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.